About us

Dr.Max Group is owned by Penta Investments

Dr. Max Group is fully owned by Penta Investments, an investment group operating Europe, that has been involved in the healthcare industry since 2002, investing in health insurance, hospitals, outpatient clinics, pharmacies and laboratories. Dr. Max streams of business include pharmacies, wholesale and sales and marketing divisions.


Instant development from 2004

2004

Entering Czech market through acquisition of 50% share in the company Česká lékárna.

2005

Entering Slovak and Polish markets

2008

Dr.Max opens its 100th pharmacy

2011

Establishment of the company Dr.Max Pharma (private label company)

2014

Starting off online sales channel

2017

Entering Romanian, Serbian and Italian markets

2018

Completing biggest acquisition in history (takeover of A&D Pharma in Romania)


Group management

  • Leonardo Ferrandino

    President & CEO of Dr.Max Group

    Leonardo Ferrandino

    President & CEO of Dr.Max Group

    “At Dr. Max Group our long-term strategy is to empower people to work in new ways in order to enhance our customer experience.”

  • Thomas Bornemann

    CFO of Dr.Max Group

    Thomas Bornemann

    CFO of Dr.Max Group

    “The Mission of our finance department is to ensure rationale business decisions and enable efficient capital allocation as well as healthy business growth by providing transparency, relevant insights, constructive business partnering and also necessary financial resources.”

  • Ivo Šenkyřík

    Head of M&A of Dr.Max Group

    Ivo Šenkyřík

    Head of M&A of Dr.Max Group

    “We strive to be the market leader in the countries where we operate. The expansion is one of the key pillars how to achieve this long-term goal.”

  • Piotr Szarwas

    CIO of Dr.Max Group

    Piotr Szarwas

    CIO of Dr.Max Group

    “Research from the last two decades has proven that organizations which invest in technology and choose the path of innovation significantly increase their market share, financial figures and overall competitiveness. The role of IT in Dr.Max is to ensure that through proper investments into technology we bring value to our clients, our employees and our stakeholders.”

  • Erikjan Lantink

    Chief HR Officer of Dr.Max Group

    Erikjan Lantink

    Chief HR Officer of Dr.Max Group

    “Our employees stand behind the success of Dr.Max. It has been and it will always be our first priority to select, develop and keep the right talents in order to achieve our long term company strategies in all areas.“

  • Miguel Martins da Silva

    Chief Supply Chain Officer of Dr.Max Group

    Miguel Martins da Silva

    Chief Supply Chain Officer of Dr.Max Group

    “Supply Chain in the Dr.Max Group is about deploying best in class technology and processes and doing things better, in an innovative and efficient way, every day. While we are at this, we never forget that in the end, the customer is the center of all our work and all the decisions we make are therefore focused on how to serve him better.”

  • Luboš Korbelář

    Chief Commercial Officer of Dr.Max Group

    Luboš Korbelář

    Chief Commercial Officer of Dr.Max Group

    “Commercial department is part of the DNA of Dr.Max Group. Our work is to split best pieces of DNA and replicate it to other countries.”

  • Kenneth Nielsen

    Chief Digital Officer of Dr.Max Group

    Kenneth Nielsen

    Chief Digital Officer of Dr.Max Group

    “Digital is the most recent addition to DrMax central functions. Over the coming years we will work on continuing the strong e-commerce development and omnichannel proposition. Via digital services and technologies we will be working on further enhancements of the customer experience across channels, all of it with the ambition of securing Dr.Max meets and exceeds the continuous evolving customer needs.“


We improve the quality of accessible and affordable care by expanding our assortment of pharmaceutical products and services

To support our vision of becoming a pharmaceutical leader even beyond Central Europe, we do not base our development only on selling pharmaceuticals. With our wide portfolio of private brands, we can offer our clients high-quality products, including affordable medicines. Our distribution centers and first-rate laboratories mean we can provide other services at a very high level as well.

  • Our clients should always feel welcome and supported.

  • Our clients should always feel welcome and supported.

    Our clients should deal with helpful staff who give professional advice, complex care and great service.

    Our clients will recognize that we are a brand that is not afraid to innovate and consistently drive up industry standards in order to bring them the most effective health and wellbeing solutions at the best possible value.

  • Our staff will receive first-class training in how to best meet the needs of their clients.

  • Our staff will receive first-class training in how to best meet the needs of their clients.

    Our staff’s health and wellbeing as well as their personal development will be a top priority for the business allowing them to reach their full professional potential.

    We encourage our staff to be brave in sharing ideas on how we can improve operations, increase profitability and deliver high quality solutions to our clients.

  • We are committed to developing long-term, mutually beneficial business relationships with all of our partners and suppliers.

  • We are committed to developing long-term, mutually beneficial business relationships with all of our partners and suppliers.

    We share our partners’ commitment to delivering great quality products and services to our clients.

    We take our commercial relationships seriously and welcome and support innovations that benefit our clients and staff.

Contact

Dr. Max BDC, s.r.o.

Na Florenci 2116/15
110 00 Prague 1
[email protected]

The Dr.Max Group is owned by the Central European investment group Penta, established in 1994. Penta’s business areas include health care, financial services, manufacturing, retail businesses and real estate development. Penta manages a single fund for its partners, the shareholders in the company. The companies in Penta’s portfolio employee more than 43,000 people, and the Group’s asset value reached € 11.1 billion in 2020. Penta operates in more than 10 European countries and has offices in Prague, Bratislava, Warsaw and Munich.

icon-twitter icon-linkedin icon-facebook